Individual variability in cyclosporin A sensitivity: The assessment of functional measures on CD28-mediated costimulation of human whole blood T lymphocytes

Journal of Interferon and Cytokine Research

Volumn 23, Issue 2, 2003, Pages 91-99

  Härtel, Christoph ^a   Hammers, Hans Jörg ^a   Schlenke, Peter ^a   Fricke, Lutz ^a   Schumacher, Nina ^a   Kirchner, Holger ^a   Müller Steinhardt, Michael ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD69 ANTIGEN; CYCLOSPORIN A; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; MESSENGER RNA; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BIOLOGICAL MARKERS; BLOOD CELLS; CELL DIVISION; CELLS, CULTURED; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MALE; RECEPTORS, INTERLEUKIN-2; RNA, MESSENGER; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; VARIATION (GENETICS);

EID: 0345382796     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999003321455480     Document Type: Article

References (23)

1. STILLER, C.R. (1996). An overview of the first decade of cyclosporine. Transplant. Proc. 28, 2005-2012.
2. HO, S., CLIPSTONE, N., TIMMERMANN, L., NORTHROP, J., GRAEF, I., FIORENTINO, D., NOURSE, J., and CRABTREE, G.R. (1996). The mechanism of action of cyclosporin A and FK506. Clin. Immunol. Immunopathol. 80, S40-S45.
3. ELLIOTT, J.F., LIN, Y., MIZEL, S.B., BLEACKLEY, R.C., HARNISH, D.G., and PAETKAU, V. (1984). Induction of interleukin 2 messenger RNA inhibited by cyclosporin A. Science 226, 1439-1441.
4. RAO, A. (1994). NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes. Immunol. Today 15, 274-281.
5. ROBEY, E., and ALLISON, J.P. (1995). T-cell activation: integration of signals from the antigen receptor and costimulatory molecules. Immunol. Today 16, 306-310.
6. GEGINAT, J., CLISSI, B., MORO, M., DELLABONA, P., BENDER, J.R., and PARDI, R. (2000). CD28 and LFA-1 contribute to cyclosporin A-resistant T cell growth by stabilizing the IL-2 mRNA through distinct signaling pathways. Eur. J. Immunol. 30, 1136-1144.
7. BOUMA, G.J., HOLLANDER, D.A., MEER-PRINS, E.M., VAN BREE, S.P., VAN ROOD, J.J., VAN DER WOUDE, F.J., and CLAAS, F.H. (1996). In vitro sensitivity to prednisolone may predict kidney rejection after steroid withdrawal. Transplantation 62, 1422-1429.
8. HARTEL, C., BEIN, G., KIRCHNER, H., and KLUTER, H. (1999). A human whole-blood assay for analysis of T-cell function by quantification of cytokine mRNA. Scand. J. Immunol. 49, 649-654.
9. HAMMERS, H.J., KIRCHNER, H., and SCHLENKE, P. (2000). Ultraviolet-induced detection of halogenated pyrimidines: simultaneous analysis of DNA replication and cellular markers. Cytometry 40, 327-335.
10. KIRCHNER, H., KLEINICKE, C., and DIGEL, W. (1982). A whole-blood technique for testing production of human interferon by leukocytes. J. Immunol. Methods 48, 213-219.
11. BATIUK, T.D., PAZDERKA, F., ENNS, J., DECASTRO, L., and HALLORAN, P.F. (1995). Cyclosporine inhibition of calcineurin activity in human leukocytes in vivo is rapidly reversible. J. Clin. Invest. 96, 1254-1260.
12. JUNE, C.H., LEDBETTER, J.A., GILLESPIE, M.M., LINDSTEN, T., and THOMPSON, C.B. (1987). T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell. Biol. 7, 4472-4481.
13. HARTEL, C., BEIN, G., MÜLLER-STEINHARDT, M., and KLUTER, H. (2001). Ex vivo induction of cytokine mRNA expression in human blood samples. J. Immunol. Methods 249, 63-71.
14. VAN GOOL, S.W., CEUPPENS, J.L., WALTER, H., and DE BOER, M. (1994). Synergy between cyclosporin A and a monoclonal antibody to B7 in blocking alloantigen-induced T-cell activation. Blood 83, 176-183.
15. VAN GOOL, S.W., DE BOER, M., and CEUPPENS, J.L. (1993). CD28 ligation by monoclonal antibodies or B7/BB1 provides an accessory signal for the cyclosporin A-resistant generation of cytotoxic T cell activity. J. Immunol. 150, 3254-3263.
16. APPLEMAN, L.J., BEREZOVSKAYA, A., GRASS, I., and BOUSSIOTIS, V.A. (2000). CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression. J. Immunol. 164, 144-151.
17. OHNISHI, H., LEDBETTER, J.A., KANNER, S.B., LINSLEY, P.S., TANAKA, T., GELLER, A.M., and KOTB, M. (1995). CD28 cross-linking augments TCR-mediated signals and costimulates superantigen responses. J. Immunol. 154, 3180-3193.
18. HARTEL, C., FRICKE, L., SCHUMACHER, N., KIRCHNER, H., and MÜLLER-STEINHARDT, M. (2002). Delayed cytokine mRNA expression kinetics after T-lymphocyte costimulation: a quantitative measure of the efficacy of cyclosporin A-based immunosuppression. Clin. Chem. 48, 2225-2231.
19. RAFIQ, K., KASRAN, A., PENG, X., WARMERDAM, P.A., COOREVITS, L., CEUPPENS, J.L., and VAN GOOL, S.W. (1998). Cyclosporin A increases IFN-gamma production by T cells when costimulated through CD28. Eur. J. Immunol. 28, 1481-1491.
20. GRUNIG, G., CORRY, D.B., LEACH, M.W., SEYMOUR, B.W., KURUP, V.P., and RENNICK, D.M. (1997). Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J. Exp. Med. 185, 1089-1099.
21. MÜLLER-STEINHARDT, M., KOCK, N., HÄRTEL, C., KIRCHNER, H., and STEINHOFF, J. (2001). Production of monokines in patients under polysulphone haemodiafiltration is influenced by the ultrafiltration flow rate. Nephrol. Dial. Transplant. 16, 1830-1837.
22. MÜLLER-STEINHARDT, M., HÄRTEL, C., MÜLLER, B., KIRCHNER, H., and FRICKE, L. (2002). The interleukin-6-174 promoter polymorphism is associated with long-term kidney allograft survival. Kidney Int. 62, 1824-1827.
23. BATIUK, T.D., PAZDERKA, F., ENNS, J., DE CASTRO, L., and HALLORAN, P.F. (1996). Cyclosporine inhibition of leukocyte calcineurin is much less in whole blood than in culture medium. Transplantation 61, 158-161.